Abstract: The present invention relates to organic semiconducting compounds of formula (I) wherein X1 is C, Si or Ge; X2 is 0, S or Se; and X3 is N or P as well as to organic electronic devices comprising such organic semiconducting compounds.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
August 24, 2021
Assignee:
Merck Patent GmbH
Inventors:
Daniel Becker, Andreas Taugerbeck, Martin Schraub
Abstract: Imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof are useful as BTK inhibitors.
Type:
Grant
Filed:
April 8, 2019
Date of Patent:
August 24, 2021
Assignee:
Merck Patent GmbH
Inventors:
Pascale Gaillard, Jeyaprakashnarayanan Seenisamy, Lesley Liu-Bujalski, Richard D. Caldwell, Justin Potnick, Hui Qiu, Constantin Neagu, Reinaldo Jones, Annie Cho Won, Andreas Goutopoulos, Brian A. Sherer, Theresa L. Johnson, Anna Gardberg
Abstract: The invention relates to a process for the production of an electronic component comprising a self-assembled monolayer (SAM) using compounds of the formula I R1-(A1-Z1)r—(B1)n—(Z2-A2)s-Sp-G ??(I) in which the groups occurring have the meanings defined in claim 1; the present invention furthermore relates to the use of the components in electronic switching elements and to compounds for the production of the SAM.
Type:
Application
Filed:
June 11, 2019
Publication date:
August 19, 2021
Applicant:
MERCK PATENT GMBH
Inventors:
Peer KIRSCH, Sebastian RESCH, Henning SEIM, Marc TORNOW, Takuya KAMIYAMA, Gerd-Volker ROESCHENTHALER, Romana PAJKERT
Abstract: The present invention provides methods of treating cancer using pyrimidine and pyridine compounds which are inhibitors of Bruton's tyrosine kinase (BTK).
Type:
Application
Filed:
April 16, 2021
Publication date:
August 12, 2021
Applicant:
Merck Patent GmbH
Inventors:
Bayard R. HUCK, Samantha M. Goodstal, Claude Gimmi-McKim
Abstract: The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises a PD-1 axis binding antagonist, a TGF? inhibitor and a DNA-PK inhibitor, optionally together with one or more additional chemotherapeutic agents or radiotherapy. The therapeutic combination is particularly intended for use in treating a subject having a cancer that tests positive for PD-L1 expression.
Abstract: The invention concerns a filtration assembly for microbiological testing and a method of using the filtration assembly for that purpose. The filtration assembly (1) comprises a ring-like membrane support (10) holding a filtration membrane (11), a cylindrical reservoir (20) of which opposite axial ends have openings and one axial opening is removably and fluid-tightly attachable to the membrane support (10) to define a sample volume adjacent to the filtration membrane (11) on one axial side of the membrane support (10); and a lid device (40) removably and fluid tightly attachable to the other axial opening of the reservoir (20) to close the opening. Further, the lid device (40) is removably and fluid tightly attachable to the membrane support (10) so as to seal the one axial side of the membrane support (10) from the environment.
Type:
Application
Filed:
September 4, 2018
Publication date:
August 12, 2021
Applicant:
Merck Patent GmbH
Inventors:
Philippe RIVAT, Mathieu ARRAULT, Vincent SCHAAL
Abstract: An electrically switchable optical modulator for modulating an optical wavefront transmitted therethrough, comprising a birefringent first optical element and a birefringent second optical element each having respective ordinary and extraordinary refractive indices. A birefringent liquid crystal material is sandwiched between the first and second optical elements. The extraordinary refractive index of the liquid crystal material is electrically switchable between: a first state in which it has a first value; and, a second state in which it has a second value different from the first value. One or both of the first value and the second value is un-matched to the extraordinary refractive index of the first optical element in respect of light polarised in a first direction of linear polarisation, and is un-matched to the extraordinary refractive index of the second optical element in respect of light polarised in a second direction of linear polarisation orthogonal to the first direction.
Abstract: The present invention relates to benzotriazole derivatives selected from the group of compounds of formulae Ia, Ib and Ic as defined in claim 1, to mesogenic media comprising the compounds of formulae Ia, Ib and Ic, and to the use of these compounds and mesogenic media in optical, electronic and electro-optical applications, in particular in devices for regulating the passage of energy from an outside space into an inside space, for example in windows.
Abstract: The present invention relates to a method for forming an organic EL element having at least one pixel type comprising at least three different layers including a hole injection layer (HIL), a hole transport layer (HTL) and an emission layer (EML), characterized in that the HIL, the HTL and the EML of at least one pixel type are obtained by depositing inks wherein the layers are annealed after said depositing steps in a first, second and third annealing step and the difference of the annealing temperature of the first and of the second annealing step is below 35° C., preferably below 30° C., more preferably below 25° C. and the annealing temperature of the third annealing step is no more than 5° C.
Type:
Grant
Filed:
January 29, 2018
Date of Patent:
August 3, 2021
Assignee:
Merck Patent GmbH
Inventors:
Hsin-Rong Tseng, Thorsten Schenk, Peter Levermore, Anja Jatsch
Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.
Type:
Grant
Filed:
September 4, 2019
Date of Patent:
August 3, 2021
Assignee:
Merck Patent GmbH
Inventors:
Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
Abstract: [Problem] To provide a high heat resistance resist composition and a pattern formation method using the composition. [Solution] The present invention provides a chemically amplified negative-type resist composition comprising a particular polymer and a particular crosslinking agent, and this composition makes it possible to form a resist pattern of high sensitivity, of excellent resolution and of strong heat-resistance.
Abstract: A mixing device (1) for cyclically imparting a force on an external surface (A) of a bag (B) for agitating a content (C) of the bag (B), the mixing device (1) comprising a lever (2) supported so as to be able to pivot about a pivot (3), a weight (4) provided on a first side of the lever (2), a driver (5) arranged to cooperate with the lever (2), a motor (6) for moving the driver (5) to lift the first side of the lever (2) with the weight (4) against gravity and to drop the first side against the external surface (A) of the bag (B), and a holder (7) for supporting the mixing device (1) such that the first side of the lever (2) can contact the external surface (A) of the bag (B) in the drop motion.
Abstract: The present invention provides a calibration device for an optical detector comprising a light emitting diode 1, and an electronic circuit 3 for driving the light emitting diode 1, wherein the electronic circuit 3 is a constant current generator configured to supply a constant driving current to the light emitting diode 1 in the range of 0.5 to 25 ?A. Furthermore, the present invention provides a setting device for setting at least one calibration point for a calibration device as described above. The setting device comprises a light detector 51 configured to output a signal representing the light emission intensity of a calibration device under examination, a controller 53 for controlling the constant driving current of the calibration device under examination, and a calibration point setting means 55 for setting at least one calibration point for the calibration device under examination.
Type:
Application
Filed:
May 29, 2019
Publication date:
July 29, 2021
Applicant:
MERCK PATENT GMBH
Inventors:
Fabrice COMINI, Frederick G. BARGOOT, Victor ETRE
Abstract: A liquid-crystalline media (LC media) containing a low-molecular-weight, non-polymer component, and a combination of self-alignment additives for vertical alignment of two or more of the specified kinds (formulae IA to IM). The combination of two or more self-alignment additives affect homeotropic (vertical) alignment of the LC media at a surface or the cell surfaces of a liquid-crystal display (LC display).
Type:
Grant
Filed:
December 19, 2018
Date of Patent:
July 27, 2021
Assignee:
MERCK PATENT GMBH
Inventors:
Graziano Archetti, Izumi Saito, Rocco Fortte, Edward Plummer, Dmitry Ushakov, Helmut Haensel, Melanie Klasen-Memmer
Abstract: The present invention relates to pigments which comprise niobium-doped titanium dioxide as well as a layer encapsulating the niobium-doped titanium dioxide, to polymer materials containing same and to the use of said pigments as laser absorbing additive in products comprising at least one polymer material and said encapsulated niobium-doped titanium dioxide containing pigments.
Abstract: The present invention refers to a crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to 4-(2-hydroxyethyl)-morpholine is from 1:0.3 to 1:2.0 (in mol/mol) and/or hydrates and/or solvates thereof as well as to a process of obtaining the same.
Type:
Application
Filed:
July 2, 2019
Publication date:
July 22, 2021
Applicant:
MERCK PATENT GMBH
Inventors:
Rudolf MOSER, Viola GROEHN, Ruth BOEHNI STAMM, Fritz BLATTER, Martin SZELAGIEWICZ
Abstract: The invention relates to a liquid-crystalline medium, in particular based on a mixture of polar compounds, and to the use thereof for an active-matrix display, in particular based on the VA, SA-VA, IPS, PS-IPS, FFS, PS-FFS, UB-FFS or PS-UB-FFS effect.
Abstract: The invention relates to a polymerizable LC material comprising one or more di- or multireactive mesogenic compounds and one or more compounds of formula S0, S1 or S2, wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film with improved thermal durability and UV stability obtainable from a corresponding polymerizable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerizable LC material for optical, electro-optical, decorative or security devices.
Abstract: The present invention is directed to crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid comprising (i) 5-methyl-(6S)-tetrahydrofolic acid, (ii) sodium and (iii) an organic base having a pKa value from 6 to 11; wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to the sodium is from 1:0.5 to 1:1.5 and the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to the organic base is 1:0.5 to 1:1.5 and/or hydrates and/or solvates thereof, as well as, a processes of obtaining the same.
Type:
Grant
Filed:
March 28, 2018
Date of Patent:
July 20, 2021
Assignee:
MERCK PATENT GMBH
Inventors:
Rudolf Moser, Viola Groehn, Fritz Blatter, Martin Szelagiewicz, Ruth Boehni Stamm, Markus Ruettimann, Giuseppe Lapadula
Abstract: The present invention relates to a novel styrenic polymer and to the novel composition comprised of this polymer and a solvent; wherein the styrenic polymer has a polydispersity from 1 to 1.3 and further wherein each polymer chain of the styrenic polymer is capped with one end group of structure 1), wherein, and L is a linking group selected from the group consisting of a direct valence bond, oxy (—O—), carbonyloxy, (—(C?O)—O—), carbonate (—O—(C?O)—O—); L2 is a C-1 to C-20 substituted or unsubstituted alkylene spacer, an arylene spacer or a direct valence bond, R, is hydrogen, a halide, a C-1 to C-20 alkyl moiety, or a C-1 to C-20 alkyloxy moiety, m is an integer from 1 to 3; and (I) represent the direct valence bond attaching the end group 1) to the end of the polymer chain of the styrenic polymer. In another aspect of this invention it pertains to the use of this composition to create self-assembly process.
Type:
Grant
Filed:
December 19, 2017
Date of Patent:
July 20, 2021
Assignee:
Merck Patent GMbH
Inventors:
Hengpeng Wu, JiHoon Kim, Jianhui Shan, Durairaj Baskaran, Md S. Rahman